Genetically Modified Knockin and Knockout Mice

The NIAID intramural program has twenty laboratories and research units, located in Bethesda and Rockville, Maryland; and Hamilton, Montana, containing over 110 independent basic and clinical researchers working to exploit fundamental knowledge of infectious agents and the immune system toward improved health for our nation and the world. The Research Technologies Branch was formed within the Division of Intramural Research (DIR) to provide state-of-the-art research services and technologies. The purpose of this requirement is to provide specific knockout or knockin (KO/KI) mice based on up to 25 constructs provided by DIR investigators. When explaining capabilities regarding KO/KI mice, respondents should also address whether they are capable of providing lentiviral transgenics. All small businesses including veteran-owned small business, service-disabled veteran-owned small business, HBCU, HUBZone small business, small disadvantaged business, and women-owned small business concerns should respond with a capability statement by July 10, 11:00am Eastern Time. Teaming arrangements are encouraged. All questions must be directed, in writing, to Alexander Kramer at kramera@niaid.nih.gov. The NAICS code for this notice is 112990 which has a size standard of $750,000 (No large businesses should respond to this announcement.) Capability statements must reference similar work that has been performed by the contractor and the dollar value of that work. This is a market survey, not a request for proposals.